Kevin Chih-Yang Huang

Engineered sTRAIL-armed MSCs overcome STING deficiency to enhance the therapeutic efficacy of radiotherapy for immune checkpoint blockade

S. Chiang, Ji-An Liang, W. Chen, 2022, Cell Death & Disease.

Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma

Wei-Chung Cheng, S. Chiang, K. Chao, 2021, Theranostics.

Protein phosphatase 2A inactivation induces microsatellite instability, neoantigen production and immune response

S. Chiang, W. Chen, K. Chao, 2021, Nature Communications.

Dual inhibition of TGFβ signaling and CSF1/CSF1R reprograms tumor-infiltrating macrophages and improves response to chemotherapy via suppressing PD-L1.

S. Chiang, W. Chen, K. Chao, 2022, Cancer letters.

DNMT1 constrains IFNβ-mediated anti-tumor immunity and PD-L1 expression to reduce the efficacy of radiotherapy and immunotherapy

S. Chiang, K. Chao, Ji-An Liang, 2021, Oncoimmunology.

Prognostic relevance of programmed cell death 1 ligand 2 (PDCD1LG2/PD-L2) in patients with advanced stage colon carcinoma treated with chemotherapy

S. Chiang, K. Chao, W. Chen, 2020, Scientific Reports.

Immunogenic Cell Death by the Novel Topoisomerase I Inhibitor TLC388 Enhances the Therapeutic Efficacy of Radiotherapy

S. Chiang, K. Chao, Yi-Wen Huang, 2021, Cancers.